An observational study in Joint Effusion, Septic Arthritis and Arthritis, sponsored by Centre Hospitalier le Mans. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-09.
Sponsored by Centre Hospitalier le Mans · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Arthritis, Infectious with a site in France — 3 open to participants now, 4 under way, none of them phase 3. Arthritis, Infectious · France.
Among the 13 studies in Arthritis, Infectious with a site in France, this one is the only one that started in 2020, is one of 9 observational ones, and was the 7th registered.
51 studies on the registry are indexed under Arthritis, Infectious; 12 are open to participants now.
Browse Arthritis, Infectious studies →3 of the 13 studies in Arthritis, Infectious with a site in France are open now. Recruiting first, the newest first:
University Hospital, Brest · Sites in France
Poitiers University Hospital · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 7 Arthritis, Infectious studies recruiting now, 2 set no upper age limit and 5 stop at 75 or younger; 6 take children under 18; none take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2020.
This study's enrollment of 328 is above the median of 100 across 30 observational studies indexed under Arthritis, Infectious.
Median enrollment 115 across the 4 interventional studies, 100 across the 9 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 9 most frequent:
Centre Hospitalier le Mans is the lead sponsor of 44 studies on the registry; 18 are open to participants now.
Centre Hospitalier le Mans has 1 study filed under Arthritis, Infectious — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Arthritis, Infectious with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Development and validation of a simple diagnostic tool predictive of the aseptic character of joint effusion in the primary care setting.
In accordance with guidelines and because of the potential gravity that this situation could represent, any joint effusion must be considered as a septic arthritis until proven otherwise, thus justifying an arthrocentesis and an adequate treatment. Nevertheless, because of epidemiology in primary care, this pragmatic attitude is quite commonly obscured and practices vary according to the experience of the doctor and his personal habits. As a result, the arthrocentesis is not commonly performed and anti-inflammatory treatment, whether based on NSAIDs or corticosteroids, is even sometimes administered to the patient despite the contrary guidelines. Although usually effective, this attitude is however not without risks. In this context, it seems interesting to develop a simple, reproducible and applicable diagnostic tool in a primary care setting for predicting the risk of septic arthritis.
This study is therefore aimed at the development and validation of a predictive score based on simple clinical and paraclinical data (such as the macroscopic appearance of the synovial fluid removed) in a patient with an effusion, whatever either the clinical presentation, whether isolated or integrated in a more complex clinical presentation, whether associated with locoregional inflammatory or general signs or not.
All adult patients presenting with at least one clinical joint effusion accessible to arthrocentesis, interesting a native non operated joint, without any general antibiotic therapy in the previous 15 days.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Arthrocentesis to determine the nature of the effusion (septic or aseptic).
Presence of a septic arthritis
Presence of more than 2000 cells/mL and bacterial growth in the articular fluid.
Time frame: 10 days after the arthrocentesis.
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2020 to primary completion in Mar 2022, 24 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier le Mans